imipramine has been researched along with Metabolic Diseases in 5 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, AN | 1 |
| Ligade, SS | 1 |
| Sharma, JN | 1 |
| Shukla, P | 1 |
| Elased, KM | 1 |
| Lucot, JB | 1 |
| Kolisek, M | 1 |
| Montezano, AC | 1 |
| Sponder, G | 1 |
| Anagnostopoulou, A | 1 |
| Vormann, J | 1 |
| Touyz, RM | 1 |
| Aschenbach, JR | 1 |
| Busch, KT | 1 |
| Schulz, H | 1 |
| El-Nabbout, S | 1 |
| Scott, WA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? A Randomized, Double-blinded, Placebo-controlled Clinical Trial[NCT01845259] | Phase 2 | 103 participants (Actual) | Interventional | 2013-04-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for imipramine and Metabolic Diseases
| Article | Year |
|---|---|
GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Body Weight; Chole | 2015 |
PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases.
Topics: Animals; Cardiovascular Diseases; Cation Transport Proteins; Chronic Disease; Humans; Imipramine; In | 2015 |
[The acute psychiatric emergency].
Topics: Acute Disease; Aged; Alcoholism; Amitriptyline; Brain Ischemia; Cognition Disorders; Consciousness D | 1981 |
[Buccal pH and salivary pathology. Work at the Clinic of Stomatology and Maxillo-facial Surgery. University of Paris].
Topics: Adolescent; Adult; Aged; Butyrophenones; Candidiasis; Chemical Phenomena; Chemistry; Colorimetry; El | 1974 |
Rheumatology.
Topics: Acute Disease; Aged; Analgesics; Arthritis, Rheumatoid; Chronic Disease; Diazepam; Female; Gout; Hum | 1972 |